Skip to content

Study on the mechanism of Bushen Huoxue Recipe in the prevention and treatment of degenerative lumbar spinal stenosis based on multimodal in situ mass spectrometry imaging technology

Study on the mechanism of Bushen Huoxue Recipe in the prevention and treatment of degenerative lumbar spinal stenosis based on multimodal in situ mass spectrometry imaging technology

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2022000096
Enrollment
Unknown
Registered
2022-06-23
Start date
2022-09-22
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Degenerative lumbar spinal stenosis

Interventions

none:none

Sponsors

Medical Experimental Center of China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients who meet the above diagnostic criteria and are clearly diagnosed as degenerative lumbar spinal stenosis, and those whose lumbar spine MRI showed thickening of the ligamentum flavum of the responsible segment >4mm were included in the experimental group. 2. Patients with burst fracture or lumbar spine trauma and no obvious lumbar degenerative disease on lumbar spine MRI were included. 3. Patients who are ineffective after conservative treatment for more than 3 months and have clear surgical indications must be routinely excluded from surgical treatment. 4. Age 40 to 75 years old. 5. Patients who participated voluntarily and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Under the age of 40 or over 75, pregnant or breastfeeding women, patients with other spinal diseases such as ankylosing spondylitis, vertebral compression fractures and tumors. 2. Patients with definite lumbar spondylolisthesis of grade II or higher; patients who plan to undergo revision surgery with lumbar internal fixation. 3. Accompanied by ossification of the ligamentum flavum. 4. Combined with diabetes and other diseases that have a potential impact on the ligamentum flavum. 5. Special populations who are not suitable to participate in clinical research (blind, deaf, mute, intellectual or mental disorders, etc. who cannot cooperate with them). 6. Patients with serious primary diseases such as heart, brain, liver, kidney, hematopoietic system or other contraindications to surgery.

Design outcomes

Primary

MeasureTime frame
Biochemical tests;histopathology;Videography;Proteomics;Transcriptomics;

Countries

China

Contacts

Public ContactZhang Ping

Wangjing Hospital of China Academy of Chinese Medical Sciences

Pinglele@sina.com13601382826

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026